The assessment of tumor oxygenation is a crucial factor in cancer therapy and may be carried out using fluorine MRI once fluorine probes have been distributed within the tumor.
INTRODUCTION
Hypoxia is a characteristic feature of locally-advanced solid tumors resulting from an imbalance between oxygen supply and consumption [1] . Hypoxia has been shown to play a key role in tumor resistance to radiation therapy [2] and also in decreasing the efficacy of certain cytotoxic drugs [3] . Numerous studies have demonstrated that tumor hypoxia, in addition to diminishing therapeutic efficacy, plays a major role in malignant progression [4] .
Methods to determine tumor oxygenation are therefore of crucial importance for the prediction of therapeutic outcomes. Many current methods, such as Eppendorf electrodes [5] , near-infrared spectroscopy [6] , electron paramagnetic resonance imaging [7] , susceptibility magnetic resonance imaging based methods [8] or 19 F magnetic resonance imaging oximetry [6, 9] have been used in preclinical studies but have either been highly invasive, nonquantitative, or have lacked spatial resolution. As far as clinically available devices are concerned, MR-based techniques may be of interest, whereby, proton-based-imaging can be inserm-00785263, version 1 -5 Feb 2013 used to access blood oxygen change using the BOLD (Blood Oxygen Level-Dependent)
sequence [8] , currently widely used in clinics for functional magnetic resonance imaging (fMRI) studies. Nevertheless, this imaging technique is based on relaxivity changes that allow the depiction of oxygenation variations, but it does not enable the quantitative assessment of oxygen concentration [10] . However, recent studies have shown a high correlation between oxygen changes assessed using BOLD-imaging and oxygen levels measured using 19 F-MRI of a fluorinated oxygen probe in a preclinical model [11] .
Currently, the major limitations of 19 F -oximetry is the lack of equipment of clinical MR to perform fluorine imaging. However, such a limitation can easily be removed since it only requires the acquisition of a specific 19 F -tuned probe. Fluorine oximetry is based on the influence of oxygen tension on the relaxivity of certain fluorinated probes. In the early 80's
Clark et al. [12] showed a linear relation between longitudinal relaxivity of fluorinated probes with oxygen tension; this opened the field for MR oximetry [13] [14] [15] . Numerous fluorine probes were tested as oxygen sensors and numerous protocols have been proposed to optimize the injection of the fluorinated probes. Zhao et al. proposed a multiple deposit of the probe along 3 orthogonal directions in order to ensure that the interrogated regions are representative of the whole tumor [16] . However, as reported by these authors [11] , the deposit induced signal voids on the anatomical proton images that can jeopardize the information that can be extracted from the anatomical data set.
To overcome this drawback, we propose the development of lipid nanocapsules to carry the fluorinated probe. Lipid nanocapsules are engineered using FDA-approved constituents (i.e. Solutol and Lipoid) that are prepared by a solvent-free and low -energy process [17] , they are able to deliver drugs to a target [18] and, amazingly, they are characterized by an intrinsic effect on Multi-Drug-Resistance via the inhibition of P-gp [19] .
According to the preparation process used, this nano-scaled platform can encapsulate hydrophilic [20] and lipophilic [21] 
Formulation process
The quantities of PFCE (oil phase), water and NaCl (aqueous phase), Solutol ® HS15 and These different formulations were stored at 4°C and size stability over the experimental time was assessed.
Physico-chemical characterization of PFCE-LNCs

Size measurement.
The average hydrodynamic diameter Z-average (Z-ave) and the polydispersity index (PdI) of PFCE-LNC were determined by dynamic light scattering using a Malvern Zetasizer ® (Nano Series DTS 1060, Malvern Instruments S.A., Worcestershire, UK) fitted with a 633 nm laser beam (helium-neon laser, 4 mW) at a fixed scattered angle of 173°. Measurements were made at 25°C, with 0.89 cP viscosity and a refractive index of 1.33. The autocorrelation function was fitted using the cumulant analysis method to obtain Z-ave and PdI values. The PFCELNCs were diluted with pure water (dilution factor: 60) before size measurement; each measurement was performed three times.
Interface characterization -Drop tensiometer.
Adsorption kinetics measurements were carried out at the oil-water interface by means of a pendant drop method [26] 
Electrophoretic measurements.
Dialysis of PFCE-LNC (5 mL) was performed (Spectra/Por ® Biotech Cellulose Ester Dialysis
Membrane, MWCO = 50 kDa) for one week against pure water (obtained through a milli-Q apparatus, Millipore, Saint Quentin en Yvelines, France), changing the water twice a day. At the end of dialysis and after size verification (similar to hydrodynamic diameter as before dialysis), the PFCE-LNCs were diluted with saline (dilution factors: 60, 600 and 6,000) to obtain different ionic strengths (from 2.5 to 50mM). An electrophoretic mobility test was performed using a Malvern Zetasizer ® (Nano Series DTS 1060). Three different PFCE-LNC batches were prepared to obtain the mean value of electrophoretic mobility  standard deviation (SD) vs. NaCl concentrations.
The surface properties of the nanoparticles were studied by soft-particle analysis using the Ohshima theory [27, 28] . Ohshima showed that the electrophoresis mobility of a soft particle This method allows the calculation of ZN and  which characterize the electric properties of the surface of particles; ZN represents the spatial charge density in the polyelectrolyte region and  is a physical constant characterizing the degree of resistance to liquid flow in the polyelectrolyte region. The reciprocal of , which is 1/, has the dimension of length and can be regarded as the "softness" parameter of the NP surface. All electrophoretic mobilitiy and softness values reported were the mean of three measurements with separately prepared batches.
Polyethylene glycol titration.
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The dialysis of PFCE-LNCs (5mL) was performed (Spectra/Por ® Biotech Cellulose Ester Dialysis Membrane, MWCO = 50 kDa) against 100mL of pure water (obtained through a milli-Q apparatus, Millipore, Saint Quentin en Yvelines France) at room temperature under magnetic stirring, to remove PEG chains (from Solutol) not associated to PFCE-LNC. The PEG concentration was determined by the use of a colorimetric method, based on the complex formation between PEG and iodine [29] . 100µL aliquots were collected vs. time (from 0 to 120-h) in the dialysis external medium and immediately replaced with 100µL of pure water.
To this 100-µL aliquot was added 25µL of KI/I 2 (0.01 and 0.02-g.mL -1 for I 2 and KI, respectively), and absorbance was measured at 492nm, 5 minutes after the addition. The calibration curve was assessed using Solutol solutions. Experiments were performed in triplicate.
Magnetic resonance imaging protocols
In vitro studies
The 
The average T1 value of the 3 measurements per oxygen concentration was used for the linear fit of 1/T1 vs. pO2, from which the anoxic intercept A and slope S were derived.
In vivo studies
Tumor induction
Animal care and use were in strict accordance with the regulations of the French Ministry of Agriculture. Brain tumors were induced by stereotaxic inoculation of glioma cells as previously described [30] . Briefly, 7-8week-old male SCID mice (Charles Rivers, France)
were anesthetized with a mixture of Rompun® (Xylazine, Bayer AG, Leverkusen, Germany)
and Clorketam® (Kétamine, Vétoquinol, Lure, France) before being fixed in a stereotaxic holder. Through a small hole drilled in the skull (anterior −0.5mm, lateral 2mm, depth −3mm according to the bregma), 5μl of a suspension of 50,000 grade IV glioma cells were injected over a 10-minute time period into the caudate putamen of the right hemisphere [31] .
Tumor growth control and pO 2 measurement
After 8-10 weeks, the animals were scanned using a Bruker Biospec 70/20 operating at a prior to the RARE pattern in order to better the depiction of the tumors. The duration of the inversion delay was fixed at 600 ms, enough time to allow the annulation of the normal parenchyma [32] .When a tumor was detected, the mice underwent an intratumoral stereotactic injection of 8µL of the PFCE-LNCs using a convection-enhanced delivery protocol [33] . The fluorine acquisitions were performed immediately and could be repeated for at least a week using the same protocol as the one used for the in vitro study. The resonant circuit was a 40mm 1 H/ 19 F coil, and the sequence used was the same as the one used for the in vitro studies.
RESULTS AND DISCUSSION
PFCE-LNC formulation.
The morphology of LNC results in an oily core surrounded by lecithins and a non-ionic surfactant [34] . The formulation protocol is based on a phase-inversion process due to the specific properties of the non-ionic surfactant, PEG-HS present in Solutol. Then, PEG-HS
gives an oil-in-water emulsion (O/W) at room temperature and a water-in-oil emulsion (W/O) at high temperature [17] .
This inversion process was tested to obtain PFCE nanocapsules (PFCE-LNC), using PFCE as the oil in the formulation. First of all, it appeared that the oil and water phases were not easy to mix due to the high density of PFCE (d ~ 2) and the size of the dispersed droplets produced were large (hydrodynamic diameter (Z-ave) ~ 450nm) with a high polydispersity index (PdI ~ 0.7).
In the literature, sonication in combination with high pressure is often used to obtain PFCELNCs [35, 36] . In our case, sonication at atmospheric pressure was used to improve the dispersion of the oil and water phases before the phase-inversion process. A first cycle of temperature was added before the sonication step to allow the Lipoïd to melt. Various sonication powers were tested (0, 3, 5 and 10W) prior to the phase-inversion process. Without
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sonication, no PFCE-LNCs were formulated. When the sonication power was increased, PFCE-LNCs were formulated with sizes ca. 300nm when the power was set to 3W, and ca.
200nm when the power was set to 5 or 10W. The higher sonication power led to a narrowing of the PFCE-LNC population (PdI = 0.14 vs 0.22 for 10W vs 5W).
As a consequence, the formulation process had to include four steps: i) temperature increase of the formulation from room temperature to 95°C to allow the Lipoïd melting; ii) sonication of the formulation to the power of 10-W for 1 minute; iii) 3 temperature cycles from 25°C to 95°C; iv) and finally, during the last temperature decrease, when the temperature reaches 70°C, a rapid cold dilution with deionized water (dilution factor: 3.5).
The composition is however a crucial point for PFCE-LNC formulation using this low-energy process. Indeed, using Fan's formulation composition [35] , i.e. PFCE 2g, Lipoïd 0.12g, glycerin 0.09g and deionized water 2.91g, larger particles were obtained with a hydrodynamic diameter (Z-ave) ~ 250nm and a higher polydispersity index (PdI ~ 0.25). Interestingly, those nanoparticles are however comparable in size with those obtained using the high-energy process described by Fan et al [35] .
Therefore, with respect to the phase-inversion process and the composition used in this work, For the system with a PFCE core, a size limit was observed while for LNCs with Labrafac core, size was dependent on the oil -surfactant ratio [37] . w/w Total for deionized water. A slight increase in size and the PdI (about 10%) was observed over a 3 month period of time. In addition, during storage and according to the high density of the oil, sedimentation of the PFCE-LNC was observed but a simple dispersion under stirring allows the material to be recovered without size modification. Interestingly, it should then be possible to concentrate the PFCE-LNCs using the property of sedimentation for these nanocarriers.
PFCE-LNC characterization.
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PFCE-LNCs appeared to be different from classical Labrafac-LNCs, at least in terms of size dependency with respect to formulation composition. The density of the PFCE (~2) may account for this observation but the interaction of the surfactant may also be peculiar with this oil. As a consequence, the amphiphilic properties of PEG-HS were carefully examined at a PFCE-water interface. A PFCE pendant drop was formed using a drop tensiometer in a water phase containing various concentrations of Solutol from 0 to 0.4g.L -1 . A significant decrease of the surface tension from 45 to 20mN.m -1 was observed when Solutol concentrations were increased ( Figure 3 ). PEG-HS from Solutol acted as a surfactant at the PFCE-water interface, as it was observed for with Labrafac oil [38] . This may then explain the feasibility of producing lipid nanocapsules with PFCE.
As PFCE-LNC size was larger than those reported for Labrafac-LNC, the quantity of PEG-HS involved in nanoparticles was determined. PFCE-LNC formulation was dialyzed to remove all the free materials after formulation. The PEG chain concentration was obtained using KI/I 2 titration. As observed in Figure 4 , about 20% (w/w) of PEG was free after the formation of the LNCs corresponding to the free PEG chains present in commercial Solutol.
Therefore, PEG-HS from Solutol totally participated into the formation of nanoparticle shells.
In order to appreciate the softness of PFCE-LNCs, Ohshima's model was applied [28] . This model was used to fit the experimental electrophoretic mobility of PFCE-LNCs, diluted by factors 60, 600 and 6,000, vs. NaCl concentrations ( Figure 5 for the dilution factor 600). No difference for the experimental electrophoretic mobility was obtained, whatever the dilution of PFCE-LNCs, and the experimental data points were fitted using the Ohshima model
showing that the PFCE-LNCs could be considered as a charged, hard sphere surrounded by a non-charged, soft-shell. The two fitting parameters were determined: ZN = -0.67 ± 0.21 . one measured in Labrafac-LNC (~ 0.1nm) [39] and suggested that the organization within the PFCE-LNCs shell was unusual.
In order to characterize this peculiar organization of the HS-PEG at the interface PFCE-water in the PFCE-LNCs, the HS-PEG density was calculated. According to Minkov et al. [40] , when HS-PEG molecules are perfectly and compactly organized at the Labrafac-water interface, the surface occupied by one molecule of surfactant is about 1nm². In PFCE-LNC, such a calculation was performed (Appendix 1) and showed that each HS-PEG molecule only occupied 0.1nm². This lower value and therefore higher density can only be reached with a chaotic arrangement of HS-PEG ( Figure 6 ).
Thus, PFCE-LNC can be described as a PFCE spherical core surrounded by lipoïd and PEG-HS whose organization at the interface oil-water is chaotic. The shell layer accessible to ions, calculated using the Ohshima model at 3.5 nm, corresponded to the accessible depth inside this chaotic organization. As it currently is, the thickness of the shell is unknown but has to be above the thickness of the shell in labrafac-LNC. The thickness of the shell and its chaotic organization may then impede the diffusion of O 2 molecules toward the fluorinated sensor, a compulsory phenomenon to assess pO 2 . In order to test this hypothesis, an assessment of relaxivity changes of the PFCE entrapped in the PFCE-LNC as a function of surrounding pO 2 was performed.
PFCE-LNC and MRI.
T1 Measurement of PFCE-loaded nanocapsules in vitro and relationship with pO 2 .
First of all, a comparison between the sensitivity of free PFCE and of encapsulated PFCE with respect to oxygenation was performed. No significant changes were observed. Indeed, T1 measurements performed at 20°C lead to values of 2380ms, 1300ms and 582ms for the free PFCE when the samples were exposed to 0%, 21% or 100% O2 and to values of 2296ms, 1397ms and 607ms for encapsulated PFCE. To characterize the sensitivity of the PFCE- Assuming a T1 value of 1,150ms, the pO 2 value at 37, 36 or 35°C is 78, 73 or 67mmHg.
Despite this potential drawback in pO 2 measurements, one may assume that in vivo, the temperature will be constant and therefore, that pO 2 changes will reflect biochemical processes.
PO 2 measurement in vivo
The stereotactic injection of 8µL of the PFCE-loaded nanocapsules suspension was sufficient to allow the detection of a significant fluorine signal (signal-to-noise ratio for TR = 6,000ms was about 20) , that can be used to assess tumor pO 2 (Figures 8A&8B). On the images presented, when the mouse was anesthetized for 20 minutes using isoflurane vaporized with pure oxygen (Figure 8A ), the tumor pO 2 was calculated on three consecutive sets of images, assuming a tumor temperature of 37°C, at 159, 186 and 177mmHg leading to an average value of 174 ± 14mmHg. When the vaporizing gas was switched to air, the tumor pO 2 inserm-00785263, version 1 -5 Feb 2013 dropped below 50mmHg within 10 minutes to tend to values below 10mmHg within 30 minutes in the presented primary grade IV brain tumor model (Figure 8 B) . As previously described, the profile of the pO 2 change with time can be fitted with a monoexponential function whose time constant reflect mainly tumor oxygen consumption as perfusion has a limited effect [9, 41] . In the type of tumor explored ( Figure 8C ), this time constant (k) was calculated at k= 0.16 min -1 . This measurement can be repeated over time for at least 10 days in this fast growing tumor model. Currently, the temporal resolution of the pO 2 assessment is ca. 4min, and may be significantly reduced using the SNAP-IR sequence presented by Jordan [42] assuming that the achievable spatial resolution will be compatible with the small tumors present in the mouse brain. This figure also showed that despite the entrapment of the sensor within the nanocapsules, oxygen molecules can access the PFCE through the constituted surfactant shell.
CONCLUSIONS
Nanoscaled platform capable of measuring brain tumor pO 2 using fluorine MRI was synthesized. Despite the high density and the high lipophilicity of the fluorinated pO 2 sensor,
i.e. perfluoro-15-crown-5-ether, the low-energy, phase-inversion process used to produce lipid nanocapsules could be implemented. The resulting nanocapsules are composed of a perfluoro-15-crown-5-ether core surrounded by a chaotic arrangement of polyethylene glycol hydroxystearate that does not interfere with O 2 molecule diffusion toward the oxygenation sensor. Once injected in brain tumors using a convection-enhanced delivery protocol, a pO 2 map of the tumor can then be performed.
